Skip to main content
Premium Trial:

Request an Annual Quote

Carl Hull, Thomas MacMahon

Former Gen-Probe Chairman and CEO Carl Hull and former Laboratory Corporation of American Chairman and CEO Thomas MacMahon have joined the board of Ortho Clinical Laboratories as independent members. 

Hull has more than 30 years of experience in the life sciences and diagnostics markets, and in addition to his stint at Gen-Probe, he held executive positions at Applied Biosystems, Applied Imaging, Ventana Medical Systems, and Abbott Diagnostics. 

MacMahon is currently an executive partner at Foundation Medical Partners. He began his career at Roche. 

Also joining Ortho Clinical Diagnostics' board as independent members are former Fenwal President and CEO Ron Labrum and Covidien President and CEO José Almeida. 

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.